Follow Flash Finance FollowTelegram
23tech score
/ 100

Viyash Scientific Limited (VIYASH) — Technical Setup

₹220.31 +0.88%   Weak Downtrend Normal Volatility Strong bearish

As of 2026-11-02 close Sector: Pharma Drug Manufacturers - Specialty & Generic All technical setups →

Summary

Viyash Scientific Limited is in a weak downtrend on the daily chart. RSI(14) is 43.2, MACD is above its signal line, ADX reads 22. Volume in the latest session was 0.4× its 20-day average. Over three months it has underperformed the Nifty 50 by 8.7 percentage points. Nearest support is ₹214.78 and resistance ₹227.22. Its technical score is 23/100 (strong bearish).

Trend (daily)
Bearish
Trend (weekly)
Bearish
Trend (monthly)
—
RSI (14)
43.16
MACD
Bullish
ADX (14)
21.80
Volume vs 20d avg
0.36×
Support
₹214.78 (−2.5%)
Resistance
₹227.22 (+3.1%)
RS vs Nifty (3M)
-8.71%
RS rating
61.00

🧮 How the 23/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend0/20
  • Close above 20-day EMA (-1.96)0/3
  • 20-day EMA above 50-day EMA0/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up0/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (21.80)0/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum8/20
  • RSI(14) in the bullish zone (55-70 best) (43.16)2/6
  • MACD line above its signal line4/4
  • MACD line above zero (-7.16)0/3
  • 12-day rate of change positive (-5.44)0/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months (-8.71)0/2
Volume0/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.09)0/5
  • More volume on up days than down days (20 sessions) (0.68)0/5
  • Close above 20-day VWAP (-1.26)0/5
Volatility9/20
  • Daily range (ATR%) contained — ≤2.5% scores full (4.42)2/6
  • Price in the upper half of its Bollinger Bands (0.40)2/5
  • Shallow drawdown from the 52-week high (-26.07)1/5
  • Volatility contracting (20-day volatility below its 6-month median) (43.20)4/4
Support / Resistance6/20
  • Room to the next resistance (≥8% scores full) (3.14)1/5
  • Support close below (a tight, definable stop) (2.51)5/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-26.07)0/5

🧭 Regime: Weak Downtrend

Normal Volatility — Bollinger width is in the 72th percentile of the last six months.

Suits: Defensive. Price is below its averages. Oversold bounces happen, but the path of least resistance is lower — wait for a base.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the SuperTrend (10,3) rules for VIYASH — supertrend (10,3) flips to an uptrend.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly———
Weekly▼ Bearish46.44-7.15
Daily▼ Bearish43.161.13

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bearish, weekly ADX 30.95.

📶 Volume & VWAP

Relative volume
0.36×
5d / 20d volume
0.92×
Volume ROC (10d)
+47.62%
Up/down volume
0.68×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.09
VWAP 20d
₹223.12 (-1.26%)
VWAP 50d
₹255.04 (-13.62%)
Anchored VWAP · 52W low
₹254.57 (-13.46%)
Anchored VWAP · 52W high
₹257.40 (-14.41%)
Anchored VWAP · YTD
₹251.34 (-12.35%)
Avg turnover (20d)
₹54 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks.

💪 Relative strength

vs Nifty 1M
-10.20%
vs Nifty 3M
-8.71%
vs Nifty 6M
+10.45%
vs Nifty 1Y
—
RS rating
61.00
Mansfield RS
—
vs Pharma index 3M
-14.72%
vs sector peers 3M
-12.21%

VIYASH ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹280.00+27.1%3
Resistance₹263.85+19.8%3
Resistance₹244.07+10.8%8
Resistance₹227.22+3.1%2
Close₹220.31—
Support₹214.78−2.5%3
Support₹197.10−10.5%3
Support₹189.62−13.9%1
Support₹178.13−19.1%1

52-week range: ₹178.13 – ₹298.00 (-26.07% from the high).

🌀 Fibonacci

Measuring the down-swing from ₹298.00 (2026-07-06) to ₹197.10 (2026-10-23). Price has retraced 23.0% of it.

RatioPriceDistance
23.6% retracement₹220.91+0.3% nearest
38.2% retracement₹235.64+7.0%
50.0% retracement₹247.55+12.4%
61.8% retracement₹259.46+17.8%
78.6% retracement₹276.41+25.5%
127.2% extension₹169.66-23.0%
161.8% extension₹134.74-38.8%
200.0% extension₹96.20-56.3%

Next Fibonacci time zone: 89 sessions from the swing start ≈ 2026-11-11 (approximate — exchange holidays are not modelled).

🕯️ Candlesticks (last 5 sessions)

No classic candlestick pattern in the last five sessions.

↗️ Divergences

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
DIVISLABDivi's Laboratories Limited ₹9,945.50 +1.69% 94 Uptrend 92.00
ACUTAASAcutaas Chemicals Limited ₹3,892.60 -2.77% 87 Uptrend 96.00
SMSPHARMASMS Pharmaceuticals Limited ₹504.15 -1.41% 87 Strong Uptrend 92.00
CORONACORONA Remedies Limited ₹2,171.10 +1.00% 86 Uptrend 84.00
ZYDUSLIFEZydus Lifesciences Limited ₹1,240.50 -0.40% 85 Uptrend 85.00
PPLPHARMAPiramal Pharma Limited ₹239.92 +0.42% 83 Strong Uptrend 90.00
DRREDDYDr. Reddy's Laboratories Limited ₹1,342.00 -0.74% 82 Strong Uptrend 76.00
AARTIDRUGSAarti Drugs Limited ₹453.80 +4.27% 81 Strong Uptrend 77.00
ALIVUSAlivus Life Sciences Limited ₹1,447.60 +2.28% 81 Strong Uptrend 92.00
GLANDGland Pharma Limited ₹3,066.60 -0.95% 80 Uptrend 94.00
🔗 More on VIYASH

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI